Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-19-029139)

Filing Details

Accession Number:: 0001127602-19-029139
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-26 16:06:41
Reporting Period:: 2019-09-25

Accepted Time:: 2019-09-26 16:06:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492422	Apellis Pharmaceuticals Inc.	APLS	Pharmaceutical Preparations (2834)	271537290

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1657720	Pascal Deschatelets	C/O Apellis Pharmaceuticals, Inc 6400 Westwind Way, Suite A Crestwood KY 40014	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-09-25	20,531	$25.24	882,753	No	4	S	Direct
Common Stock	Disposition	2019-09-25	1,010	$25.64	881,743	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale originated from established 10b5-1 trading plan.
Average Sale Price within $1. Min $24.58-Max $25.56
Average Sale Price within $1. Min $25.58-Max $25.82